Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus

M. Kotani, I. Tanaka, Y. Ogawa, T. Suganami, T. Matsumoto, S. Muro, Y. Yamamoto, A. Sugawara, Y. Yoshimasa, N. Sagawa, S. Narumiya, K. Nakao

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

PGE2 is known to induce uterine contraction by increasing intra-cellular Ca2+. In the present study, to investigate other functions of PGE2 in human uterus, two EP3 isoforms were isolated by the RT-PCR method using human uterus polyadenylated ribonucleic acid (RNA). These EP3 isoforms, named EP3-V and EP3-VI, are composed of 402 and 393 amino acid residues, respectively, which are unique compared with EP3 isoforms of other species. Their N-terminal 359 amino acid residues are identical to those of previously reported human EP3 isoforms, whereas the two isoforms contained a novel amino acid sequence in their C-terminal tails. The dissociation constant values of EP3-V and EP3-VI for PGE2 were 3.9 and 1.4 nmol/L, respectively, which were consistent with those of previously reported EPa isoforms. Signaling experiments revealed that M&B28767, an EP3 agonist, not only inhibited forskolin-induced cAMP concentrations, but also activated mitogen-activated protein kinase in Chinese hamster ovary cells stably expressing EP3-V and EP3-VI. These responses were abolished by treatment with pertussis toxin. In addition, M&B28767 increased cAMP concentrations in EP3-VI-expressing cells, whereas it did not in EP3-V-expressing cells. M&B28767 did not stimulate phosphoinositide turnover in EP3-V- or EP3-VI-expressing cells. EP3-V and EP3-VI messenger RNAs (mRNAs) were detected abundantly in human uterus, whereas weak, but substantial, bands were detected in the lung and kidney in RT-PCR specific for each mRNA. In situ hybridization revealed EP3-V and EP3-VI mRNAs in the human myometrium, but not in the endometrium. The present study suggests that EP3-V and EP3-VI are possibly involved in the proliferation of cells in human myometrium.

Original languageEnglish
Pages (from-to)4315-4322
Number of pages8
JournalJournal of Clinical Endocrinology and Metabolism
Volume85
Issue number11
DOIs
Publication statusPublished - Jan 1 2000
Externally publishedYes

Fingerprint

Receptors, Prostaglandin E, EP3 Subtype
Signal transduction
Uterus
Signal Transduction
Protein Isoforms
Dinoprostone
Myometrium
Amino Acids
Messenger RNA
Uterine Contraction
Polymerase Chain Reaction
Pertussis Toxin
Colforsin
Endometrium
Phosphatidylinositols
Cricetulus
Mitogen-Activated Protein Kinases
In Situ Hybridization
Tail
Amino Acid Sequence

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. / Kotani, M.; Tanaka, I.; Ogawa, Y.; Suganami, T.; Matsumoto, T.; Muro, S.; Yamamoto, Y.; Sugawara, A.; Yoshimasa, Y.; Sagawa, N.; Narumiya, S.; Nakao, K.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 85, No. 11, 01.01.2000, p. 4315-4322.

Research output: Contribution to journalArticle

Kotani, M, Tanaka, I, Ogawa, Y, Suganami, T, Matsumoto, T, Muro, S, Yamamoto, Y, Sugawara, A, Yoshimasa, Y, Sagawa, N, Narumiya, S & Nakao, K 2000, 'Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus', Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 11, pp. 4315-4322. https://doi.org/10.1210/jcem.85.11.6989
Kotani, M. ; Tanaka, I. ; Ogawa, Y. ; Suganami, T. ; Matsumoto, T. ; Muro, S. ; Yamamoto, Y. ; Sugawara, A. ; Yoshimasa, Y. ; Sagawa, N. ; Narumiya, S. ; Nakao, K. / Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus. In: Journal of Clinical Endocrinology and Metabolism. 2000 ; Vol. 85, No. 11. pp. 4315-4322.
@article{bd0d545aac7544b99052f54f174337cf,
title = "Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus",
abstract = "PGE2 is known to induce uterine contraction by increasing intra-cellular Ca2+. In the present study, to investigate other functions of PGE2 in human uterus, two EP3 isoforms were isolated by the RT-PCR method using human uterus polyadenylated ribonucleic acid (RNA). These EP3 isoforms, named EP3-V and EP3-VI, are composed of 402 and 393 amino acid residues, respectively, which are unique compared with EP3 isoforms of other species. Their N-terminal 359 amino acid residues are identical to those of previously reported human EP3 isoforms, whereas the two isoforms contained a novel amino acid sequence in their C-terminal tails. The dissociation constant values of EP3-V and EP3-VI for PGE2 were 3.9 and 1.4 nmol/L, respectively, which were consistent with those of previously reported EPa isoforms. Signaling experiments revealed that M&B28767, an EP3 agonist, not only inhibited forskolin-induced cAMP concentrations, but also activated mitogen-activated protein kinase in Chinese hamster ovary cells stably expressing EP3-V and EP3-VI. These responses were abolished by treatment with pertussis toxin. In addition, M&B28767 increased cAMP concentrations in EP3-VI-expressing cells, whereas it did not in EP3-V-expressing cells. M&B28767 did not stimulate phosphoinositide turnover in EP3-V- or EP3-VI-expressing cells. EP3-V and EP3-VI messenger RNAs (mRNAs) were detected abundantly in human uterus, whereas weak, but substantial, bands were detected in the lung and kidney in RT-PCR specific for each mRNA. In situ hybridization revealed EP3-V and EP3-VI mRNAs in the human myometrium, but not in the endometrium. The present study suggests that EP3-V and EP3-VI are possibly involved in the proliferation of cells in human myometrium.",
author = "M. Kotani and I. Tanaka and Y. Ogawa and T. Suganami and T. Matsumoto and S. Muro and Y. Yamamoto and A. Sugawara and Y. Yoshimasa and N. Sagawa and S. Narumiya and K. Nakao",
year = "2000",
month = "1",
day = "1",
doi = "10.1210/jcem.85.11.6989",
language = "English",
volume = "85",
pages = "4315--4322",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Multiple signal transduction pathways through two prostaglandin E receptor EP3 subtype isoforms expressed in human uterus

AU - Kotani, M.

AU - Tanaka, I.

AU - Ogawa, Y.

AU - Suganami, T.

AU - Matsumoto, T.

AU - Muro, S.

AU - Yamamoto, Y.

AU - Sugawara, A.

AU - Yoshimasa, Y.

AU - Sagawa, N.

AU - Narumiya, S.

AU - Nakao, K.

PY - 2000/1/1

Y1 - 2000/1/1

N2 - PGE2 is known to induce uterine contraction by increasing intra-cellular Ca2+. In the present study, to investigate other functions of PGE2 in human uterus, two EP3 isoforms were isolated by the RT-PCR method using human uterus polyadenylated ribonucleic acid (RNA). These EP3 isoforms, named EP3-V and EP3-VI, are composed of 402 and 393 amino acid residues, respectively, which are unique compared with EP3 isoforms of other species. Their N-terminal 359 amino acid residues are identical to those of previously reported human EP3 isoforms, whereas the two isoforms contained a novel amino acid sequence in their C-terminal tails. The dissociation constant values of EP3-V and EP3-VI for PGE2 were 3.9 and 1.4 nmol/L, respectively, which were consistent with those of previously reported EPa isoforms. Signaling experiments revealed that M&B28767, an EP3 agonist, not only inhibited forskolin-induced cAMP concentrations, but also activated mitogen-activated protein kinase in Chinese hamster ovary cells stably expressing EP3-V and EP3-VI. These responses were abolished by treatment with pertussis toxin. In addition, M&B28767 increased cAMP concentrations in EP3-VI-expressing cells, whereas it did not in EP3-V-expressing cells. M&B28767 did not stimulate phosphoinositide turnover in EP3-V- or EP3-VI-expressing cells. EP3-V and EP3-VI messenger RNAs (mRNAs) were detected abundantly in human uterus, whereas weak, but substantial, bands were detected in the lung and kidney in RT-PCR specific for each mRNA. In situ hybridization revealed EP3-V and EP3-VI mRNAs in the human myometrium, but not in the endometrium. The present study suggests that EP3-V and EP3-VI are possibly involved in the proliferation of cells in human myometrium.

AB - PGE2 is known to induce uterine contraction by increasing intra-cellular Ca2+. In the present study, to investigate other functions of PGE2 in human uterus, two EP3 isoforms were isolated by the RT-PCR method using human uterus polyadenylated ribonucleic acid (RNA). These EP3 isoforms, named EP3-V and EP3-VI, are composed of 402 and 393 amino acid residues, respectively, which are unique compared with EP3 isoforms of other species. Their N-terminal 359 amino acid residues are identical to those of previously reported human EP3 isoforms, whereas the two isoforms contained a novel amino acid sequence in their C-terminal tails. The dissociation constant values of EP3-V and EP3-VI for PGE2 were 3.9 and 1.4 nmol/L, respectively, which were consistent with those of previously reported EPa isoforms. Signaling experiments revealed that M&B28767, an EP3 agonist, not only inhibited forskolin-induced cAMP concentrations, but also activated mitogen-activated protein kinase in Chinese hamster ovary cells stably expressing EP3-V and EP3-VI. These responses were abolished by treatment with pertussis toxin. In addition, M&B28767 increased cAMP concentrations in EP3-VI-expressing cells, whereas it did not in EP3-V-expressing cells. M&B28767 did not stimulate phosphoinositide turnover in EP3-V- or EP3-VI-expressing cells. EP3-V and EP3-VI messenger RNAs (mRNAs) were detected abundantly in human uterus, whereas weak, but substantial, bands were detected in the lung and kidney in RT-PCR specific for each mRNA. In situ hybridization revealed EP3-V and EP3-VI mRNAs in the human myometrium, but not in the endometrium. The present study suggests that EP3-V and EP3-VI are possibly involved in the proliferation of cells in human myometrium.

UR - http://www.scopus.com/inward/record.url?scp=17744382792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744382792&partnerID=8YFLogxK

U2 - 10.1210/jcem.85.11.6989

DO - 10.1210/jcem.85.11.6989

M3 - Article

C2 - 11095474

AN - SCOPUS:17744382792

VL - 85

SP - 4315

EP - 4322

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -